Advertisement

Topics

Biocon's biosimilars withdrawn in EU

07:08 EDT 17 Aug 2017 | pharmaphorum

Shares in Biocon have fallen after the company withdrew two filings for biosimilars in Europe because of ongoing concerns over its manufacturing facility. The company said the withdrawal of its Herceptin (trastuzumab) and Neulasta (pegfilgrastim) ...

Original Article: Biocon's biosimilars withdrawn in EU

NEXT ARTICLE

More From BioPortfolio on "Biocon's biosimilars withdrawn in EU"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...